Production (Stage)
Hemostemix Inc.
HMTXF
$0.0999
$0.016319.50%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -93.70% | -2.51% | 37.39% | 48.49% | 65.85% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 172.13% | 74.96% | -44.73% | -20.89% | -31.71% |
| Change in Net Operating Assets | 30.97% | -137.07% | 515.50% | 788.37% | 113.78% |
| Cash from Operations | -68.82% | -29.56% | 83.85% | 88.48% | 87.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -103.51% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 248.08% | 63.59% | -- | -88.28% | -76.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 200.00% | 130.23% | 114.68% |
| Cash from Financing | 308.42% | 64.14% | -98.72% | -88.23% | -90.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 479.48% | 2,293.87% | 50.19% | 89.87% | 66.16% |